A new review was published in Volume 12 of Oncoscience on October 13, 2025, titled "Targeted therapies and resistance ...

Q3 2025 Earnings Call November 13, 2025 9:00 AM ESTCompany ParticipantsPanna Sharma - President, CEO & DirectorDavid ...

The use of hair straighteners and chemical relaxers may be associated with a higher incidence of pancreatic cancer, thyroid cancer, and non-Hodgkin’s lymphoma, according to a study.

Reimbursement authority NICE published draft guidance today giving a green light to the use of Columvi (glofitamab) in ...

The survival rate of frozen eggs and embryos reaches more than 90% in good in vitro fertilization labs when a patient is ...

Oral presentation of Lynozyfic™ (linvoseltamab-gcpt) data in newly diagnosed multiple myeloma from LINKER-MM4, the first trial to evaluate a ...

New data from cohort 3 show EO2463 can be safely added to rituximab in first-line low-tumor-burden follicular lymphoma in need of treatment; All six patients responded positively ...

The drug given every three weeks via an intravenous infusion will be available from today thanks to the NHS fast-tracking access through its Cancer Drugs Fund, which provides patients with quicker ...

ANTLER phase 1 data demonstrate efficacy and durability on par with autologous CAR-T cell therapy and safety allows for ...

Hodgkin’s Lymphoma. Throughout the month of April, Brett met with the oncologist in Duluth and underwent a bone marrow biopsy ...

Researchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targeted treatments for some blood cancer patients. The cancer ...

Four-time non-Hodgkin lymphoma survivor Shell Rowe knows very well about the importance of finding the lighthearted side of ...